September 15th, 2023
•We present a protocol that can be used to conduct therapeutic drug testing with patient-derived ovarian cancer organoids.
Tags
Related Videos
Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells
Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines
Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids
Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing
Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved